| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 824.50B | 753.13B | 741.39B | 764.70B | 739.26B |
| Gross Profit | 301.10B | 271.43B | 223.94B | 188.75B | 228.32B |
| EBITDA | 143.32B | 144.25B | 99.74B | 57.45B | 114.67B |
| Net Income | 84.20B | 79.34B | 43.69B | 11.71B | 64.77B |
Balance Sheet | |||||
| Total Assets | 1.19T | 1.11T | 1.06T | 1.10T | 1.01T |
| Cash, Cash Equivalents and Short-Term Investments | 258.50B | 292.94B | 215.21B | 162.72B | 71.06B |
| Total Debt | 2.39B | 10.15B | 19.89B | 186.39B | 79.67B |
| Total Liabilities | 177.41B | 174.03B | 180.60B | 323.65B | 254.97B |
| Stockholders Equity | 1.00T | 926.01B | 868.16B | 769.25B | 746.34B |
Cash Flow | |||||
| Free Cash Flow | 85.68B | 129.87B | 219.24B | 5.34B | -163.60B |
| Operating Cash Flow | 108.51B | 129.87B | 237.09B | 44.43B | -103.66B |
| Investing Cash Flow | -18.70B | -37.87B | -25.62B | -37.68B | -27.89B |
| Financing Cash Flow | -105.15B | -33.55B | -191.28B | 80.97B | 52.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $9.66B | 15.31 | 8.22% | 1.58% | 4.39% | 2.64% | |
78 Outperform | $18.82B | 19.20 | 17.48% | 2.52% | 2.99% | 1.23% | |
75 Outperform | $8.64B | 33.02 | 23.00% | 1.95% | -0.47% | -14.81% | |
71 Outperform | $8.14B | 17.82 | 9.77% | 1.61% | 3.31% | -5.18% | |
70 Outperform | $14.27B | 25.03 | 37.29% | 1.22% | 7.72% | 19.51% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $11.66B | 43.69 | 4.12% | 4.42% | -0.06% | 3.45% |